Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

被引:0
|
作者
Makoto Araie
Kazuhisa Sugiyama
Kenji Aso
Koji Kanemoto
Kalyani Kothapalli
Casey Kopczynski
Michelle Senchyna
David A. Hollander
机构
[1] Kanto Central Hospital of the Mutual Aid Association of Public School Teachers,Department of Ophthalmology
[2] Kanazawa University Graduate School of Medical Science,undefined
[3] Aerie Pharmaceuticals Ireland Ltd. (Japan Branch),undefined
[4] Statistics and Data Corporation,undefined
[5] Aerie Pharmaceuticals,undefined
[6] Inc.,undefined
来源
Advances in Therapy | 2021年 / 38卷
关键词
Conjunctival hyperemia; Glaucoma; Intraocular pressure; Netarsudil; Rho-associated protein kinase;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1757 / 1775
页数:18
相关论文
共 50 条
  • [31] Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
    Martin, Patrick
    Cohen, Alisa
    Uddin, Sharif
    Epelbaum, Laura
    Josiah, Serene
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 885 - 896
  • [32] Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
    Sarkisian Jr, Steven R.
    Ang, Robert E.
    Lee, Andy M.
    Berdahl, John P.
    Heersink, Sebastian B.
    Burden, James H.
    Doan, Long, V
    Stephens, Kerry G.
    Kothe, Angela C.
    Usner, Dale W.
    Katz, L. Jay
    Navratil, Tomas
    OPHTHALMOLOGY, 2024, 131 (09) : 1021 - 1032
  • [33] Corneal Biomechanics for Ocular Hypertension, Primary Open-Angle Glaucoma, and Amyloidotic Glaucoma: A Comparative Study by Corvis ST
    Silva, Nisa
    Ferreira, Andre
    Baptista, Pedro Manuel
    Figueiredo, Ana
    Reis, Rita
    Sampaio, Isabel
    Beirao, Joao
    Vinciguerra, Riccardo
    Meneres, Pedro
    Meneres, Maria Joao
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 71 - 83
  • [34] Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
    Pfennigsdorf, Stefan
    Ramez, Osman
    von Kistowski, Gerrit
    Maeder, Birgit
    Eschstruth, Peter
    Froboese, Michael
    Thelen, Ulrich
    Spraul, Christoph
    Schnober, Dietmar
    Cooper, Hazel
    Laube, Thomas
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 739 - 746
  • [35] Ocular Pulse Amplitude in Patients with Asymmetric Primary Open-Angle Glaucoma
    Kac, Marcelo Jarczun
    Solari, Helena Parente
    Velarde, Guillermo Coca
    Brazuna, Rodrigo
    Cardoso, Gilberto Perez
    Ventura, Marcelo Palis
    CURRENT EYE RESEARCH, 2011, 36 (08) : 727 - 732
  • [36] Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
    Mathur, Manoj
    Ratnam, P., V
    Saikumar, S. J.
    John, Manuel
    Ravishankar, Siddharth
    Dinesh, M. B.
    Chandil, Priya
    Pahuja, Kishore
    Cherlikar, Vidya
    Wadhwani, Sunny
    Bendale, Pankaj
    Hazari, Ajit
    Mishra, Rajesh
    Deshmukh, Susheel
    Achlerkar, Rahul
    Shah, Devang
    Hingorani, Chanda
    Shah, Kaivan
    Topiwala, Pratik
    Jani, Sheetal
    Rana, Viral
    Majumdar, Nilay
    Chakrabarti, Debasis
    Dey, Rituparna
    Halder, Debabrata
    Choudhury, Sumit
    Kumar, Ajeet
    Das, Sasmita
    Nanda, Ashok
    Kumar, Vidya
    Dubey, Rama
    Kamdar, Gulam
    Pandey, Alka
    Kishanpuria, Sheetal
    Srivastava, Rajat
    Singh, Parul
    Verma, Sunil
    Sharma, Neha
    Gupta, Rajeev
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (06) : 2500 - 2503
  • [37] A Comparative Study of the Clinical Efficacy and Safety of Pneumatic Trabeculoplasty and Selective Laser Trabeculoplasty for Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
    Song, Yanling
    Song, Qiujie
    Qin, Yanhui
    Xu, Jinfeng
    Chen, Ping
    Li, Hong
    Han, Wenjie
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [38] Unpreserved latanoprost in the treatment of open-angle glaucoma and ocular hypertension. A multicenter, randomized, controlled study
    Denis, P.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2016, 39 (07): : 622 - 630
  • [39] Healthcare charges in patients who transition from ocular hypertension to primary open-angle glaucoma based on ophthalmic coding data
    Pasquale, Louis R.
    Walt, John G.
    Stern, Lee S.
    Wiederkehr, Daniel
    Malangone, Elisabetta
    Dolgitser, Margarita
    ADVANCES IN THERAPY, 2009, 26 (10) : 947 - 958
  • [40] Efficacy of brimonidine as replacement therapy in patients with open-angle glaucoma or ocular hypertension
    Lee, DA
    CLINICAL THERAPEUTICS, 2000, 22 (01) : 53 - 65